American Journal of Clinical Oncology · 2007 · 67 citations · 22 references
SRS can be used as primary treatment of brain metastases or salvage of recurrences after whole-brain radiation therapy to achieve good local control on the order of close to 80% at 1 year. The median survival of brain metastasis patients with breast cancer of 19 months appears favorable compared with the general brain metastasis population.
22
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.
Roy A. Patchell, Phillip A. Tibbs, William F. Regine et al. · PubMed · 1998 · 1.9K citations
Central nervous system metastasis from breast carcinoma autopsy study
Yoshiaki Tsukada, Ahmed Fouad, John W. Pickren et al. · Cancer · 1983 · 1.1K citations